MARK COLVIN: Scientists at the Menzies Research Institute in Hobart have made an important discovery about one of the most common drug used to treat MS.
They've found that the drug - interferon-beta- appears to boost people's ability to absorb vitamin D from sunlight.
In a study of 178 Tasmanians with MS the scientists found that patients on the drug were able to absorb three times as much vitamin D from the sun as those not on the drug.
Felicity Ogilvie reports from Hobart.
FELICITY OGILVIE: Multiple Sclerosis or MS is a disease that attacks the central nervous system.
It's been three years since the 30-year-old mother of two, Jayne England, found out that she has MS.
JAYNE ENGLAND: Within a week I basically went numb down the left side of my body and I went to the doctor's and I went and had CTs and MRIs and was diagnosed within two days. So it was a really quick diagnosis.
FELICITY OGILVIE: One of the medications that Mrs England was given to treat her MS was Interferon-beta. The drug is given to patients via injection.
And scientists at the Menzies Research Institute in Hobart have recently discovered there's a link between the drug and vitamin D.
Become a Member of MS Views and News